NG-Acyl-argininamide (cas 16709-23-2)s as NPY Y1 receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity
-
Add time:09/10/2019 Source:sciencedirect.com
NG-Acylated argininamides, covering a broad range of lipophilicity (calculated log D values: −1.8–12.5), were synthesized and investigated for NPY Y1 receptor (Y1R) antagonism, Y1R affinity and stability in buffer (NG-deacylation, yielding BIBP 3226). Broad structural variation of substituents was tolerated. The Ki (binding) and Kb values (Y1R antagonism) varied from low nM to one-digit μM. Most of the compounds proved to be sufficiently stable at pH 7.4 over 90 min to determine reliable pharmacological data in vitro. Exceptionally high instability was detected when a succinyl moiety was attached to the guanidine, probably, due to an intramolecular cleavage mechanism.
We also recommend Trading Suppliers and Manufacturers of argininamide (cas 16709-23-2). Pls Click Website Link as below: cas 16709-23-2 suppliers
Prev:Regular articleSolution structure of the HIV-2 TAR-argininamide (cas 16709-23-2) complex1☆
Next:Short communicationSyntheses of Nα-(β-naphthylsulfonylaminoglycyl)-argininamide (cas 16709-23-2)s as potential selective synthetic thrombin inhibitorsSynthèses de Nα-(β-naphthylsulfonylaminoglycyl)-argininamide (cas 16709-23-2)s, inhibiteurs potentiels sélectifs de la thrombine synthétiques) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short communicationSyntheses of Nα-(β-naphthylsulfonylaminoglycyl)-argininamide (cas 16709-23-2)s as potential selective synthetic thrombin inhibitorsSynthèses de Nα-(β-naphthylsulfonylaminoglycyl)-argininamide (cas 16709-23-2)s, inhibiteurs potentiels sélectifs de la thrombine synthétiques09/24/2019
- Regular articleSolution structure of the HIV-2 TAR-argininamide (cas 16709-23-2) complex1☆09/09/2019
- l-argininamide (cas 16709-23-2) improves the refolding more effectively than l-arginine09/08/2019
- Red-fluorescent argininamide (cas 16709-23-2)-type NPY Y1 receptor antagonists as pharmacological tools09/07/2019
- Dimeric argininamide (cas 16709-23-2)-type neuropeptide Y receptor antagonists: Chiral discrimination between Y1 and Y4 receptors09/06/2019


